Most uterine cancers arises in the endometrium or the inner lining of the uterus

The earlier the cancer is detected, the better the prognosis and the higher the Uterine Cancer Survival Rate. This is true not just for uterine cancer but to most cancers. Uterine Cancer Survival Rate is also quite higher among the latter than the former.
Caucasian Women have about 80or more % survival percentage.
African American Women have about 60 or more % survival percentage.
In most cancer cases, the earlier the stage, the higher the survival rate. At stage 0 or 1, the cancer survival rate is at its highest at 90 or more %. When the cancer reaches stage 2 or 3, expect a lower rate of survival at 60 or more %. Fortunately, most uterine cancer cases are detected as early as stage 1, when the cancer has not yet proliferated and it's easier to remove. A Uterine cancer survival rate refers to the percentage of people who were reported still living after being diagnosed with the cancer about 5 yrs ago.
As of today, around 70 or more % of the patients are in stage I, 13% in stage II, 9% stage III, and 3% stage IV.
Uterine Cancer Survival rates at five years are as follows: Stage I: 89%, stage II: 80%, stage III: 30%, and stage IV: 9%.
Patients whose cancer is only confined in the ovary and fallopian tubes, outcome with this treatment is quite high (80% uterine cancer survival rate at five years). Given that uterine cancer is amongst those type of cancers that are easily detected, uterus cancer survival rates are also pretty agreeable for those who are treated at the earliest stage possible. Most uterine cancers arises in the endometrium or the inner lining of the uterus that's why sometimes this type is called endometrial cancer.
Bear in mind that the patients are all treated with the cancer. Because certain hormonal changes are affecting the emotional aspect of women at these times, some patients may prefer not hearing their uterus cancer survival rate. Luckily, a lot of patients are also diagnosed at stage 1, substantially increasing the over-all percentage of survival for all patients with cancer of the uterus.